Search results

64 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
UNC receives $8 million grant to improve safe motherhood in Malawi
The University of North Carolina at Chapel Hill has received a five-year, $8 million grant from the Bill & Melinda Gates Foundation to improve maternal and infant health and save the lives of mothers and infants in Malawi by strengthening the President’s Maternal Health and Safe Motherhood Initiative (SMI).
Located in Biochemistry and Biophysics News / / 2013 / July
UNC receives more than $40 million from NIH for global clinical trials unit to treat and prevent HIV
The University of North Carolina at Chapel Hill has received a seven-year, more than $40 million award from the National Institutes of Health for a clinical trials unit that will implement the scientific agendas of five NIH networks devoted to HIV/AIDS treatment, prevention, and cure research.
Located in Biochemistry and Biophysics News / / 2014 / February
UNC research, diabetes expertise featured in video at international conference
The American Diabetes Association featured UNC-Chapel Hill diabetes experts and leaders in a video presented at the ADA's 78th Scientific Sessions this summer.
Located in Biochemistry and Biophysics News / / 2018 / July
UNC researchers awarded pilot grants for Zika research
UNC investigators will study diagnostics, transmission, and neurological effects of Zika, which has been reported in 62 countries and territories.
Located in Biochemistry and Biophysics News / / 2016 / June
UNC researchers discover new target for dengue virus vaccine
By re-engineering a tiny chain of amino acids in one type of dengue virus, Ralph Baric and Aravinda de Silva discover a new path toward solving the dengue vaccine dilemma. The research has the potential to transform vaccine development for other diseases, including SARS and HIV.
Located in Biochemistry and Biophysics News / / 2014 / February
UNC School of Medicine Researchers Prove HIV Targets Tissue Macrophages
Findings contradict previous studies questioning the relevance of these cells
Located in Biochemistry and Biophysics News / / 2016 / March
UNC scientists named to European Union-funded global Zika research consortium
The UNC School of Medicine was one of two U.S. institutions named to an international research consortium funded through the European Union’s Horizon 2020 Programme, which invested $49 million in Zika research and vaccine development at more than 20 laboratories in Europe and Brazil.
Located in Biochemistry and Biophysics News / / 2016 / November
UNC to Create the Next Generation, Ultra-Long-Acting Antiretroviral Formulations for HIV Treatment and Prevention
New project aims to provide long-lasting HIV treatment and/or protection from a single injection. Angela Wahl, PhD, Rahima Benhabbour, PhD, and Martina Kovarova, PhD, are collaborating to lead the work, which is funded by a $3.8-million NIH grant.
Located in Biochemistry and Biophysics News / / 2018 / October
UNC to Test Therapeutic Vaccine in People Living with HIV
A multidisciplinary research team at the University of North Carolina at Chapel Hill has been awarded more than $5.6 million from the National Institutes of Health (NIH) to test a therapeutic vaccine in people living with HIV.
Located in Vital Signs / 2017 / July 27
UNC, Duke Team up with Carrboro-based Caktus Group on HIV Gaming App
The Daily Dose app will utilize game mechanics and social networking features to improve adherence to HIV medication.
Located in Biochemistry and Biophysics News / / 2013 / October